Canada markets open in 1 hour 43 minutes

MYND Life Sciences Inc. (MYND.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 02:31PM EST
Full screen
Previous Close0.0600
Open0.0000
Bid0.0550 x N/A
Ask0.0600 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume5,044
Market Cap2.809M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    MYND Life Sciences Announces Stock Option Grant

    Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, announces a stock option grant pursuant to the Company's stock option plan. Stock Option GrantThe Company's Board of Directors has approved a stock options grant, exercisable to purchase

  • Newsfile

    Mynd Life Sciences Terminates Proposed Transaction with Tidal Psychedelics

    Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company") announces that it has terminated the non-binding memorandum of understanding ("MOU") to acquire all the issued and outstanding shares of Tidal Care Inc. o/a Tidal Psychedelics ("Tidal") as disclosed in Mynds's March 16, 2022 press release, due to differences in the strategic direction of the proposed acquisition. Mynd has advised Tidal of ...

  • Newsfile

    MYND Life Sciences Announces Chief Scientific Officer, Dr. Wilf Jefferies, Induction as a National Academy of Inventors Fellow

    Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("Mynd" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, is pleased to announce that Dr. Wilfred Jefferies, Mynd's Chief Scientific Officer, has been inducted as a Fellow of the National Academy of Inventors. Globally, the most accomplished inve